RxSight, Inc. to Present at the Bank of America Healthcare Conference
April 26, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023
April 25, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting
April 24, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
RxSight, Inc. to Present at the Needham Healthcare Conference
April 05, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
March 06, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
RxSight, Inc. to Present at the Oppenheimer Healthcare Conference
February 28, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following cataract...
RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023
February 21, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients...
RxSight, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock
February 14, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc. (“RxSight®”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery,...
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
February 08, 2023 00:45 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. (“RxSight”), an ophthalmic medical device company dedicated to improving the vision of patients following...
RxSight, Inc. Announces Proposed Public Offering of Common Stock
February 07, 2023 16:05 ET
|
RxSight, Inc.
ALISO VIEJO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery,...